HEK293T-hCLAUDIN 18.2
Strain Information
Validation Data
1. In vitro Expression of HEK293T-hClaudin18.2 cell line
hClaudin18.2 expression was measured in wild-type HEK293T cells and HEK293T-hClaudin18.2 cells by Flow Cytometry. FACS results showed that significant human Claudin18.2 expression on the HEK293T-hClaudin18.2 cell.
Figure 1. hClaudin18.2 expression in wild-type HEK293T and HEK293T-hClaudin18.2 cell lines
2. Characterization of in vivo growth kinetics
To verify whether there is the difference in tumor formation between the HEK293T -hClaudin18.2 cell line and the wild-type HEK293T cell line, both cells were subcutaneously inoculated into Balb/c nude mice. The tumor growth curve was shown in the Fig 2.
Figure 2. Tumor growth curve of HEK293T and HEK293T-hClaudin18.2 xenograft model (n=4)
Figure 3. Body weight curve of HEK293T and HEK293T-hClaudin18.2 xenograft model (n=4)
3. Expression of hClaudin18.2 in tumors
To verify the hClaudin18.2 protein expression, the tumors were dissected and seperated for single cell suspension. Robust human Claudin18.2 protein expression can be detected in the humanized modified tumors.
Figure 4. The expression of hClaudin18.2 in humanized modified tumors by FACS
Related Strain(s)
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreOur vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.
Learn more